Klinika Oczna
twitter
en ENGLISH
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Bieżący numer Archiwum Filmy Artykuły w druku O czasopiśmie Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Standardy etyczne i procedury Suplementy Zasady publikacji prac Opłaty publikacyjne
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Wyszukiwanie
Zasady redakcyjne
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Poleć ten artykuł:
Wyślij znajomemu
Udostępnij:
Artykuł przeglądowy

Ocular manifestations of COVID-19: a systematic and narrative literature review

Oliwia Sędziak
1
,
Hanna Pietruszewska
2
,
Natalia Kruszewska
3
,
Urszula Borucińska
4
,
Sabina Skrzynecka
5

  1. Faculty of Medicine, University of Opole, Poland
  2. Medical University of Lodz, Poland
  3. Provincial Hospital in Poznan, Poland
  4. Wolski Hospital, Warsaw, Poland
  5. University Clinical Hospital in Opole, Poland
KLINIKA OCZNA 2026, 128, 2:
DOI: https://doi.org/10.5114/ko.2026.160430
Data publikacji online: 2026/04/27
Plik artykułu:
- KO-00580 Ocular manifestations.pdf  [0.23 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Li YP, Ma Y, Wang N, et al. Eyes on coronavirus. Stem Cell Res 2021; 51: 102200. DOI: 10.1016/j.scr.2021.102200.
2. Wu P, Duan F, Luo C, et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol 2020; 138: 575-578.
3. Boz AAE, Atum M, Çakır B, et al. Outcomes of the ophthalmic examinations in patients infected by SARS-CoV-2. Ocul Immunol Inflamm 2021; 29: 638-641.
4. Cavalleri M, Brambati M, Starace V, et al. Ocular features and associated systemic findings in SARS-CoV-2 infection. Ocul Immunol Inflamm 2020; 28: 916-921.
5. Nasiri N, Sharifi H, Bazrafshan A, et al. Ocular manifestations of COVID-19: a systematic review and meta-analysis. J Ophthalmic Vis Res 2021; 16: 103-112.
6. Tran E, Phu V, Xu R, et al. Ocular manifestations of COVID-19: systematic review and meta-analysis. Can J Ophthalmol 2024; 59: e435-e452. DOI: 10.1016/j.jcjo.2023.08.003.
7. Lima LCF, Moraes Junior HV, Moraes HMV. COVID-19 ocular manifestations in the early phase of disease. Ocul Immunol Inflamm 2021; 29: 666-668.
8. Gascon P, Briantais A, Bertrand E, et al. Covid-19-associated retinopathy: a case report. Ocul Immunol Inflamm 2020; 28: 1293-1297.
9. Gonzalez-Lopez JJ, Felix Espinar B, Ye-Zhu C. Symptomatic retinal microangiopathy in a patient with coronavirus disease 2019 (COVID-19): single case report. Ocul Immunol Inflamm 2021; 29: 642-644.
10. Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol 2020; 98: e951-e959. DOI: 10.1111/aos.14472.
11. Kumar KK, Sampritha UC, Prakash AA, et al. Ophthalmic manifestations in the COVID-19 clinical spectrum. Indian J Ophthalmol 2021; 69: 691-694.
12. Bypareddy R, Rathod BLS, Shilpa YD, et al. Fundus evaluation in COVID-19 positives with non-severe disease. Indian J Ophthalmol 2021; 69: 1271-1274.
13. Dipu T, Goel R, Arora R, et al. Ocular sequelae in severe COVID-19 recovered patients of second wave. Indian J Ophthalmol 2022; 70: 1780-1786.
14. Mocanu V, Bhagwani D, Sharma A, et al. COVID-19 and the human eye: conjunctivitis, a lone COVID-19 finding – a case-control study. Med Princ Pract 2022; 31: 66-73.
15. Shroff D, Kumar S, Naidu A, et al. Retinal vasoocclusive spectrum following COVID-19. Indian J Ophthalmol 2022; 70: 1412-1415.
16. Wan KH, Lui GCY, Poon KCF, et al. Ocular surface disturbance in patients after acute COVID-19. Clin Exp Ophthalmol 2022; 50: 398-406.
17. Güemes-Villahoz N, Burgos-Blasco B, García-Feijoó J, et al. Conjunctivitis in COVID-19 patients: frequency and clinical presentation. Graefes Arch Clin Exp Ophthalmol 2020; 258: 2501-2507.
18. Ozturker ZK. Conjunctivitis as sole symptom of COVID-19: a case report and review of literature. Eur J Ophthalmol 2021; 31: NP161-NP166. DOI: 10.1177/1120672120946287.
19. Khavandi S, Tabibzadeh E, Naderan M, et al. Coronavirus disease-19 (COVID-19) presenting as conjunctivitis: atypically high-risk during a pandemic. Cont Lens Anterior Eye 2020; 43: 211-212.
20. Ma N, Li P, Wang X, et al. Ocular manifestations and clinical characteristics of children with laboratory-confirmed COVID-19 in Wuhan, China. JAMA Ophthalmol 2020; 138: 1079-1086.
21. Marinho PM, Marcos AAA, Romano AC, et al. Retinal findings in patients with COVID-19. Lancet 2020; 395: 1610-1610.
22. Erogul O, Gobeka HH, Dogan M, et al. Retinal microvascular morphology versus COVID-19: what to anticipate? Photodiagnosis Photodyn Ther 2022; 39: 102920. DOI: 10.1016/j.pdpdt.2022.102920.
23. Casagrande M, Fitzek A, Püschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm 2020; 28: 721-725.
24. Mehta S, Pandey A. Rhino-orbital mucormycosis associated with COVID-19. Cureus 2020; 12: e10726. DOI: 10.7759/cureus.10726.
25. Ocansey S, Abu EK, Abraham CH, et al. Ocular symptoms of SARS-CoV-2: indication of possible ocular transmission or viral shedding. Ocul Immunol Inflamm 2020; 28: 1269-1279.
26. Abrishami M, Tohidinezhad F, Daneshvar R, et al. Ocular manifestations of hospitalized patients with COVID-19 in northeast of Iran. Ocul Immunol Inflamm 2020; 28: 739-744.
27. Mishra SK, Kumar N, Kumari A, et al. A cross-sectional survey of ocular problems after COVID-19 infection among healthcare workers at a teaching hospital. J Family Med Prim Care 2024; 13: 3644-3646.
28. Marquezan MC, Marquezam JP, Nascimento H, et al. Conjunctivitis related to not severe COVID-19: a case report. Ocul Immunol Inflamm 2021; 29: 631-633.
29. Cabot F, Cavuoto KM, Parel JM. Conjunctival findings in patients with coronavirus disease 2019. JAMA Ophthalmol 2021; 139: 254. DOI: 10.1001/jamaophthalmol.2020.5816.
30. Sanjay S, Srinivasan P, Jayadev C, et al. Post COVID-19 ophthalmic manifestations in an Asian Indian male. Ocul Immunol Inflamm 2021; 29: 656-661.
31. Hösel K, von der Burchard C, Schunk D, et al. [Ocular manifestations in patients with COVID-19]. Ophthalmologie 2022; 119: 807-812.
32. Cheema M, Aghazadeh H, Nazarali S, et al. Keratoconjunctivitis as the initial medical presentation of the novel coronavirus disease 2019 (COVID-19). Can J Ophthalmol 2020; 55: e125-e129. DOI: 10.1016/j.jcjo.2020.03.003.
33. Soltani S, Zandi M, Ahmadi SE, et al. Pooled prevalence estimate of ocular manifestations in COVID-19 patients: a systematic review and meta-analysis. Iran J Med Sci 2022; 47: 2-14.
34. Abdul-Salam State SE, Sfredel V, Mocanu CL, et al. Optic neuropathies post-COVID 19 – review. Rom J Ophthalmol 2022; 66: 289-298.
35. Zhao Y, Tang Y, Wang QY, et al. Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review. Front Immunol 2025; 16: 1515768. DOI: 10.3389/fimmu.2025.1515768.
36. Menuchin-Lasowski Y, Schreiber A, Lecanda A, et al. SARS-CoV-2 infects and replicates in photoreceptor and retinal ganglion cells of human retinal organoids. Stem Cell Reports 2022; 17: 789-803.
37. Ran HL, Zhou XT, Liu WJ, et al. Keep eyes on COVID-19: ophthalmic symptoms and potential transmission of SARS-CoV-2 through the oculus. Infect Dis Immun 2021; 1: 103-107.
38. Jevnikar K, Jaki Mekjavic P, Vidovic Valentincic N, et al. An update on COVID-19 related ophthalmic manifestations. Ocul Immunol Inflamm 2021; 29: 684-689.
39. de Figueiredo CS, Raony Í, Giestal-de-Araujo E, et al. SARS-CoV-2 targeting the retina: host-virus interaction and possible mechanisms of viral tropism. Ocul Immunol Inflamm 2020; 28: 1301-1304.
40. Ho D, Low R, Tong L, et al. COVID-19 and the ocular surface: a review of transmission and manifestations. Ocul Immunol Inflamm 2020; 28: 726-734.
41. Willcox MD, Walsh K, Nichols JJ, et al. The ocular surface, coronaviruses and COVID-19. Clin Exp Optom 2020; 103: 418-424.
42. Dockery DM, Rowe SG, Murphy MA, et al. The ocular manifestations and transmission of COVID-19: recommendations for prevention. J Emerg Med 2020; 59: 137-140.
43. Latalska M, Mackiewicz J. The implication of ocular manifestation of COVID-19 for medical staff and patients – systematic review. Ann Agric Environ Med 2020; 27: 165-170.
44. Khanna RC, Honavar SG. All eyes on coronavirus-what do we need to know as ophthalmologists. Indian J Ophthalmol 2020; 68: 549-553.
45. Khanna RC. Coronavirus and ophthalmology: what we know and way forward. Indian J Ophthalmol 2020; 68: 942-944.
46. Sommer A. Humans, viruses, and the eye-an early report from the COVID-19 front line. JAMA Ophthalmol 2020; 138: 578-579.
47. Lauande R, Paula JS. Coronavirus and the eye: what is relevant so far? Arq Bras Oftalmol 2020; 83: V-VI. DOI: 10.5935/0004-2749.20200057.
48. Shetty R, D’Souza S, Lalgudi VG. What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic? Indian J Ophthalmol 2020; 68: 683-687.
49. Roshanshad A, Ashraf MA, Roshanshad R, et al. Ocular manifestations of patients with coronavirus disease 2019: a comprehensive review. J Ophthalmic Vis Res 2021; 16: 234-247.
50. Sen M, Honavar SG, Sharma N, et al. COVID-19 and eye: a review of ophthalmic manifestations of COVID-19. Indian J Ophthalmol 2021; 69: 488-509.
51. Szczęśniak M, Brydak-Godowska J. SARS-CoV-2 and the eyes: a review of the literature on transmission, detection, and ocular manifestations. Med Sci Monit 2021; 27: e931863. DOI: 10.12659/MSM.931863.
52. Eissa M, Abdelrazek NA, Saady M. Covid-19 and its relation to the human eye: transmission, infection, and ocular manifestations. Graefes Arch Clin Exp Ophthalmol 2023; 261: 1771-1780.
53. Torres-Costa S, Lima-Fontes M, Falcão-Reis F, et al. SARS-COV-2 in ophthalmology: current evidence and standards for clinical practice. Acta Med Port 2020; 33: 593-600.
54. Yener AÜ. COVID-19 and the eye: ocular manifestations, treatment and protection measures. Ocul Immunol Inflamm 2021; 29: 1225-1233.
55. Gregorczyk M, Roskal-Wałek J. [Ocular symptoms in SARS-CoV-2 infection]. Pol Merkur Lekarski 2022; 50: 86-93.
56. Navarčík R, Popov I, Valašková J, et al. SARS-CoV-2 pandemic from the ophthalmologist`s perspective. A review. Cesk Slov Oftalmol 2022; 78: 217-332.
57. Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm 2020; 28: 391-395.
58. Chau CYC, Chow LLW, Sridhar S, et al. Ophthalmological considerations for COVID-19 vaccination in patients with inflammatory eye diseases and autoimmune disorders. Ophthalmol Ther 2021; 10: 201-209.
59. Tripathi A, Chaudhary R, Kushwaha S, et al. Ocular manifestations of coronavirus disease 2019: a hospital-based prospective study at a coronavirus disease dedicated tertiary center. J Curr Ophthalmol 2024; 36: 176-181.
60. Visioli G, Pirraglia MP, Lambiase A, et al. Misleading citations and publication bias in COVID-19 in ophthalmology. J Evid Based Med 2024; 17: 703-704.
61. Dong J, Chen R, Zhao H, et al. COVID-19 and ocular complications: a review of ocular manifestations, diagnostic tools, and prevention strategies. Advances in Ophthalmology Practice and Research 2023; 3: 33-38.
62. Torres BRS, Cunha CEX da, Castro LR, et al. Ocular manifestations of COVID-19: a literature review. Rev Assoc Med Bras (1992) 2020; 66: 1296-1300.

Termedia
O Wydawnictwie Oferty Newsletter Kontakt Praca
Polityka prywatności Polityka reklamowa Napisz do nas Nota prawna Regulamin
Na skróty
Aktualności Czasopisma Książki eBooki Konferencje i webinary Podcasty Mednauka
Serwisy
KONGRES TOP MEDICAL TRENDS Menedżer Zdrowia Lekarz POZ Choroby rzadkie Dermatologia Diabetologia Onkologia Neurologia Reumatologia Gastroenterologia Pulmonologia Ginekologia Kurier Medyczny Zalecenia i rekomendacje e-Praktyka Leczenia Ran Warto wiedzieć Biblioteka podcastów
e-Akademia
e-Akademia Zaburzeń Mikrobioty e-Akademia POChP e-Akademia Chorób Naczyń
© 2026 Termedia Sp. z o.o.
Developed by Termedia.